BMRA Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -0.58% compare to its pairs and should correct downwards.

Stats
Šios dienos apimtis	49 424
Vidutinė apimtis	246 254
Rinkos kapitalizacija	7.40M
EPS	$-0.110 ( Q3 \| 2024-04-12 )
Kita pelno data	( $0 ) 2024-08-23
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.190 (Sector) 42.63 (Industry) 0
ATR14	$0.00500 (1.14%)

AEMD -13.81%

AFIB -13.41%

AHCO 1.42%

AHPI 0.00%

ALGN -0.65%

ANIK -1.52%

APEN 0.00%

APYX -4.96%

ARAY 1.68%

ATEC 0.58%

AXDX 1.74%

AXGN 0.28%

AXNX -0.25%

AZYO 2.05%

BBLG 0.83%

BIOL 38.50%

BJDX -6.77%

BMRA -2.16%

BRKR -0.61%

BSGM -5.35%

BWAY 0.83%

CERS 0.57%

CFMS 0.44%

CLPT -5.11%

CODX -1.57%

CSII 0.15%

CTKB 1.64%

CTSO -9.00%

CUTR 3.42%

CVRX 2.48%

DCTH 1.70%

DXCM -1.01%

DYNT -20.97%

EAR -4.10%

ECOR -0.16%

EDAP 4.21%

ESTA 3.56%

FONR 1.46%

HJLI -1.98%

HSDT -1.99%

HSKA 0.00%

HYPR -11.00%

IART 1.36%

ICAD 0.00%

ICCM -1.99%

IINN -2.13%

INGN 2.01%

INMD 1.00%

IRIX 0.00%

IRMD -0.05%

IRTC 3.12%

ISO 0.00%

ITMR 0.00%

KIDS -0.10%

LHDX 0.00%

LIVN -0.02%

LNSR 2.74%

LUCD -5.64%

LUNG 2.76%

MASS 0.00%

MDGS 10.28%

MOTS 0.17%

MOVE -3.51%

MSON 0.00%

NAOV -5.41%

NARI 2.47%

NMRD 0.00%

NNOX 10.71%

NPCE 8.00%

NTUS 0.00%

NURO 0.27%

NUVA -2.24%

NUWE 18.57%

NVCN 0.00%

NVNO 1.55%

OBLN -5.86%

OFIX -1.63%

OM -7.00%

PACB 0.74%

PAVM 6.30%

PETV 0.00%

PODD -2.50%

PRCT 2.28%

PROF -4.88%

QIPT 3.54%

QTRX 1.62%

RCEL -0.38%

RPID -4.90%

RSLS -3.23%

RWLK 6.07%

RXST 1.81%

SGHT 1.99%

SIBN 4.02%

SIEN -18.69%

SILK 0.52%

SINT -6.98%

SOLY 0.00%

SRDX 0.17%

SRGA 0.00%

SRTS 1.72%

SWAV 0.00%

TBIO -8.29%

TCMD 3.20%

TELA -8.56%

THMO 9.52%

TIVC -1.02%

TLIS 0.72%

TMCI 0.15%

TMDI 0.00%

TMDX 1.89%

TNDM -0.35%

TNON 0.00%

UFPT 2.41%

VERO -2.71%

VIVE 0.00%

VMD 1.24%

VRAY 0.00%

VREX 0.75%

VVOS -7.11%

XAIR -7.38%

XENT 0.00%

ZIMV 3.75%

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Coste Catherine	Buy	75 000	Non-qualified stock option
2023-12-13	Moatazedi David	Buy	75 000	Non-qualified stock option
2023-12-13	Kenny John P.	Buy	75 000	Non-qualified stock option
2023-12-13	Emerson Jane	Buy	75 000	Non-qualified stock option
2023-12-13	Lu Gary	Buy	155 000	Non-qualified stock option

INSIDER POWER
100.00
Last 96 transactions
Buy: 2 712 565 \| Sell: 242 000

Koreliacija (AI algo v.1.1b): Overvalued: -0.58% $0.440 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.13 (neutral)

Trumpas: -0.36 (neutral)

Signal:(46.926) Neutral

Biomerica Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
OZEM	1
KOPN	0.924
ALKS	0.909
EA	0.9
DLTR	0.897
ASUR	0.896
IPAR	0.892
BBCP	0.891
HDSN	0.89
CABA	0.886

10 Labiausiai neigiamai susiję koreliacijos
RFAIU	-0.935
SENEA	-0.903
INDH	-0.898
CENX	-0.877
AMRK	-0.869
LWAY	-0.861
GECCI	-0.859
SOHU	-0.855
GERN	-0.855
NN	-0.854

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Biomerica Inc Koreliacija - Valiuta/Žaliavos

-0.32
( neutral )

-0.42
( neutral )

0.00
( neutral )

0.38
( neutral )

Biomerica Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$5.34M
Bruto pelnas:	$446 000 (8.35 %)
EPS:	$-0.500

FY	2023
Pajamos:	$5.34M
Bruto pelnas:	$446 000 (8.35 %)
EPS:	$-0.500

FY	2022
Pajamos:	$18.87M
Bruto pelnas:	$2.98M (15.78 %)
EPS:	$-0.360

FY	2021
Pajamos:	$7.20M
Bruto pelnas:	$496 981 (6.90 %)
EPS:	$-0.540

Financial Reports:

No articles found.

Biomerica Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Biomerica Inc

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.